Renaissance Capital logo

BIOA News

US IPO Weekly Recap: Three sizable deals trade up

BIOA

Three IPOs each raised at least $100 million this week, in a welcome bump in activity. Natural gas producer BKV (BKV) priced its IPO below the range to raise $270 million at a $1.5 billion market capitalization. Operating primarily in the...read more

BioAge Labs prices IPO at $18 midpoint after upsizing again

BioAge Labs logo

BioAge Labs, a Phase 2 biotech developing obesity therapies by targeting metabolic aging, raised $198 million by offering 11.0 million shares at $18, within the range of $17 to $19. The company had originally planned to sell 7.5 million shares before raising the...read more

Obesity biotech BioAge Labs increases shares by 40% ahead of $189 million IPO

BioAge Labs logo

BioAge Labs, a Phase 2 biotech developing obesity therapies by targeting metabolic aging, raised the proposed deal size for its upcoming IPO on Wednesday. The Richmond, CA-based company now plans to raise $189 million by offering 10.5 million shares at a price...read more

US IPO Week Ahead: Natural gas producer leads week with three sizable IPOs

BKV

As many as eight companies are expected to price their IPOs in the upcoming week, including three larger deals. BKV (BKV) plans to raise $300 million at a $1.7 billion market cap. The company is primarily focused on natural gas production in...read more